心不全の重症患者における血糖変動と死亡率との関連

Pengcheng Liu¹, Ziqi Li², Shanshan Tang¹

¹High Dependency Unit, Beijing Jianjia Rehabilitation Hospital, Beijing, China.

Scientific reports

|August 23, 2025

まとめ

高血糖変動 (血糖変動) は,重症心不全患者の死亡リスクとICU滞在期間を増加させる. 血糖の変動の管理は,より良い結果のために不可欠です.

科学分野:

クリティカルケア医療
心臓病科
内分泌学

背景:

心不全は高い死亡率で深刻な世界的な健康問題です
深刻な心不全の患者は血糖のコントロールを含む複雑な管理課題に直面します

研究の目的:

重症心不全患者の血糖変動と短期死亡率との関連を調査する.
集中治療室 (ICU) の滞在期間に対する血糖変動の影響を決定する.

主な方法:

eICU- CRDとMIMIC- IVデータベースの23, 744人の心不全患者のデータを分析した.
ICU滞在中のグルコース値の変動係数を用いて定量化された血糖変動.
多変量ロジスティック回帰,コックス比例リスクモデル,および死亡率とICU滞在期間を評価するために使用される線形回帰.

主要な成果:

最低四分位と比較して,最高四分位における血糖変動は,入院期間 (OR: 1.77) と30日間の死亡率 (HR: 1.37) の有意な増加と関連していた.
高血糖変動はICUの長期滞在と相関しており,平均2. 57日単位増加です.
病院での死亡率はU型で,30日間の死亡率は線形でした.

結論:

血糖変動の上昇は,重症な心不全患者の短期的な死亡率の独立予測因子である.
血糖の変動の管理は,患者の成果を改善し,この集団における医療資源の利用を減らすために不可欠です.
血糖変動管理戦略は,重症な心不全患者のケアを最適化するために不可欠です.

キーワード:

血糖値の変動心不全死亡率予測指標

さらに関連する動画

07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

371

05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

214

関連する概念動画

01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...

01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...

01:11

Variability: Analysis

190

Measures of variability are statistical metrics that reveal the dispersion pattern within a dataset. They are pivotal in biostatistics, providing insights into the heterogeneity within health and biological data. Variability signifies the degree to which data points diverge from one another, helping researchers understand the potential range of values and associated uncertainty within the data.
The range is a simple measure of variability, indicating the difference between the highest and...

190

01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...

01:19

Overview of Carbohydrate Metabolism

1.8K

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...

1.8K

01:15

Hypoglycemia and Glucagon

334

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...

334

関連する実験動画